Michael R. Eccles

9.7k total citations · 1 hit paper
153 papers, 6.6k citations indexed

About

Michael R. Eccles is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Michael R. Eccles has authored 153 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Molecular Biology, 34 papers in Genetics and 25 papers in Oncology. Recurrent topics in Michael R. Eccles's work include Renal and related cancers (55 papers), Epigenetics and DNA Methylation (40 papers) and RNA modifications and cancer (18 papers). Michael R. Eccles is often cited by papers focused on Renal and related cancers (55 papers), Epigenetics and DNA Methylation (40 papers) and RNA modifications and cancer (18 papers). Michael R. Eccles collaborates with scholars based in New Zealand, United States and Australia. Michael R. Eccles's co-authors include Aniruddha Chatterjee, Euan J. Rodger, Leslie A. McNoe, Anthony E. Reeve, Paul Goodyer, Shujie He, Osamu Ogawa, Marion A. Maw, Peter J. Smith and A E Reeve and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Michael R. Eccles

152 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour

1993 581 citations Michael R. Eccles et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Eccles New Zealand	41	5.1k	1.7k	971	944	890	153	6.6k
Robert G. Oshima United States	51	4.4k 0.9×	1.2k 0.7×	509 0.5×	502 0.5×	371 0.4×	119	7.5k
Paul D. Soloway United States	48	3.2k 0.6×	1.3k 0.8×	460 0.5×	2.4k 2.6×	364 0.4×	91	6.3k
Bernard Thienpont Belgium	32	3.6k 0.7×	1.1k 0.7×	481 0.5×	1.2k 1.3×	625 0.7×	81	5.4k
Mieczyslaw A. Piatyszek United States	28	7.7k 1.5×	1.6k 0.9×	209 0.2×	604 0.6×	675 0.8×	38	13.7k
Jorma Wartiovaara Finland	39	3.3k 0.6×	964 0.6×	219 0.2×	414 0.4×	380 0.4×	94	5.9k
Paul‐Henri Roméo France	52	4.6k 0.9×	654 0.4×	523 0.5×	526 0.6×	610 0.7×	151	7.7k
H. Scott Baldwin United States	44	4.1k 0.8×	819 0.5×	176 0.2×	540 0.6×	1.0k 1.2×	110	6.2k
Andréas Bikfalvi France	52	5.0k 1.0×	483 0.3×	122 0.1×	1.6k 1.7×	673 0.8×	182	8.3k
Bryan D. Young United Kingdom	61	5.2k 1.0×	1.5k 0.9×	419 0.4×	1.6k 1.7×	647 0.7×	191	9.2k
Beat W. Schäfer Switzerland	57	7.7k 1.5×	482 0.3×	259 0.3×	2.0k 2.1×	1.6k 1.8×	174	9.8k

Countries citing papers authored by Michael R. Eccles

Since Specialization

Citations

This map shows the geographic impact of Michael R. Eccles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Eccles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Eccles more than expected).

Fields of papers citing papers by Michael R. Eccles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Eccles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Eccles. The network helps show where Michael R. Eccles may publish in the future.

Co-authorship network of co-authors of Michael R. Eccles

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Eccles. A scholar is included among the top collaborators of Michael R. Eccles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Eccles. Michael R. Eccles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stockwell, Peter A., et al.. (2024). Three transposable elements exhibiting differential expression in pre-eclampsia overlap with enhancer regions. Placenta. 158. 10–13. 1 indexed citations

Li, Lei, et al.. (2023). Co-Expression of Multiple PAX Genes in Renal Cell Carcinoma (RCC) and Correlation of High PAX Expression with Favorable Clinical Outcome in RCC Patients. International Journal of Molecular Sciences. 24(14). 11432–11432. 4 indexed citations

Eccles, Michael R., et al.. (2023). Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance. International Journal of Molecular Sciences. 24(2). 1601–1601. 36 indexed citations

Ahmed, Farzana, Hsin‐Yi Tseng, Antonio Ahn, et al.. (2021). Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma. Journal of Investigative Dermatology. 142(5). 1444–1455.e10. 16 indexed citations

Ratajska, Magdalena, George A. R. Wiggins, Bożena Cybulska-Stopa, et al.. (2021). Differential Expression of BARD1 Isoforms in Melanoma. Genes. 12(2). 320–320. 4 indexed citations

Mainini, Francesco, Francesca De Santis, Giovanni Fucà, et al.. (2021). Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against Cancer. Cancers. 13(15). 3765–3765. 8 indexed citations

Tiffen, Jessamy, Stuart Gallagher, Fabian V. Filipp, et al.. (2020). EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma. Journal of Investigative Dermatology. 140(12). 2442–2454.e5. 49 indexed citations

Mainini, Francesco & Michael R. Eccles. (2020). Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy. Molecules. 25(11). 2692–2692. 159 indexed citations

Stockwell, Peter A., Euan J. Rodger, Matthew Parry, et al.. (2020). Extensive Inter-Cyst DNA Methylation Variation in Autosomal Dominant Polycystic Kidney Disease Revealed by Genome Scale Sequencing. Frontiers in Genetics. 11. 348–348. 14 indexed citations

10.

Eccles, Michael R., Aniruddha Chatterjee, & Euan J. Rodger. (2017). Identifying drivers of metastasis; towards a systematic approach. Translational Cancer Research. 6. 1 indexed citations

11.

Stevens, Aaron J., Simone L. Cree, Andrew Gibb, et al.. (2014). G-Quadruplex Structures and CpG Methylation Cause Drop-Out of the Maternal Allele in Polymerase Chain Reaction Amplification of the Imprinted MEST Gene Promoter. PLoS ONE. 9(12). e113955–e113955. 32 indexed citations

12.

Hung, Noelyn, Yu-Jen Chen, Magnus Olivecrona, et al.. (2014). Increased paired box transcription factor 8 has a survival function in Glioma. BMC Cancer. 14(1). 159–159. 12 indexed citations

13.

Chen, Yu-Jen, Hamish G. Campbell, Anna Wiles, et al.. (2008). PAX8 Regulates Telomerase Reverse Transcriptase and Telomerase RNA Component in Glioma. Cancer Research. 68(14). 5724–5732. 36 indexed citations

14.

Fukuzawa, Ryuji, Michael R. Eccles, Masahiro Ikeda, & Junichi Hata. (2003). Embryonal hyperplasia of Bowman's capsular epithelium in patients with WT1 mutations. Pediatric Nephrology. 18(1). 9–13. 9 indexed citations

15.

He, Shujie, Tae Ho Lee, Lee Lee Chu, et al.. (2003). WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2. Oncogene. 22(50). 8145–8155. 32 indexed citations

16.

Eccles, Michael R., Shujie He, Michael Legge, et al.. (2002). PAX genes in development and disease: the role of PAX2 in urogenital tract development. The International Journal of Developmental Biology. 46(4). 535–544. 79 indexed citations

17.

Chen, Fabian, Gayle B. Collin, Kenneth C. Liu, et al.. (2001). Characterization of the Murine Lbx2 Promoter, Identification of the Human Homologue, and Evaluation as a Candidate for Alström Syndrome. Genomics. 74(2). 219–227. 5 indexed citations

18.

Davies, Roger P., Eric Haan, Katherine Holman, et al.. (1999). Aortic dissection, patent ductus arteriosus, iris hypoplasia and brachytelephalangy in a male adolescent. Clinical Dysmorphology. 8(4). 269???276–269???276. 15 indexed citations

19.

Cunliffe, Heather E., et al.. (1998). Cloning and Characterization of the Human PAX2Promoter. Journal of Biological Chemistry. 273(39). 25472–25479. 28 indexed citations

20.

Eccles, Michael R., Ross R. Bailey, G D Abbott, & Michael Sullivan. (1996). Unravelling the genetics of vesicoureteric reflux: a common familial disorder. Human Molecular Genetics. 5(Supplement_1). 1425–1429. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact